Versant Venture Capital Iii, L.p. - Net Worth and Insider Trading

Versant Venture Capital Iii, L.p. Net Worth

The estimated net worth of Versant Venture Capital Iii, L.p. is at least $14 Million dollars as of 2024-05-22. Versant Venture Capital Iii, L.p. is the 10% Owner of Ocular Therapeutix Inc and owns about 2,215,384 shares of Ocular Therapeutix Inc (OCUL) stock worth over $14 Million. Details can be seen in Versant Venture Capital Iii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant Venture Capital Iii, L.p. has not made any transactions after 2015-06-15 and currently still holds the listed stock(s).

Transaction Summary of Versant Venture Capital Iii, L.p.

To

Versant Venture Capital Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Venture Capital Iii, L.p. owns 7 companies in total, including Flexion Therapeutics Inc (FLXN) , PhaseRx Inc (PZRXQ) , and Ocular Therapeutix Inc (OCUL) among others .

Click here to see the complete history of Versant Venture Capital Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Versant Venture Capital Iii, L.p.

Ticker Comapny Transaction Date Type of Owner
FLXN Flexion Therapeutics Inc 2016-06-08 10 percent owner
PZRXQ PhaseRx Inc 2016-05-23 10 percent owner
OCUL Ocular Therapeutix Inc 2015-06-15 10 percent owner
2015-05-04 10 percent owner
2014-07-29 10 percent owner
2013-10-29 10 percent owner
2023-08-18 10 percent owner

Versant Venture Capital Iii, L.p. Latest Holdings Summary

Versant Venture Capital Iii, L.p. currently owns a total of 1 stock. Versant Venture Capital Iii, L.p. owns 2,215,384 shares of Ocular Therapeutix Inc (OCUL) as of June 15, 2015, with a value of $14 Million.

Latest Holdings of Versant Venture Capital Iii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCUL Ocular Therapeutix Inc 2015-06-15 2,215,384 6.10 13,513,842

Holding Weightings of Versant Venture Capital Iii, L.p.


Versant Venture Capital Iii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Versant Venture Capital Iii, L.p. has made a total of 0 transactions in Ocular Therapeutix Inc (OCUL) over the past 5 years. The most-recent trade in Ocular Therapeutix Inc is the sale of 320,000 shares on June 15, 2015, which brought Versant Venture Capital Iii, L.p. around $7 Million.

Insider Trading History of Versant Venture Capital Iii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Versant Venture Capital Iii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Versant Venture Capital Iii, L.p. Ownership Network

Ownership Network List of Versant Venture Capital Iii, L.p.

No Data

Ownership Network Relation of Versant Venture Capital Iii, L.p.


Versant Venture Capital Iii, L.p. Owned Company Details

What does Flexion Therapeutics Inc do?

Who are the key executives at Flexion Therapeutics Inc?

Versant Venture Capital Iii, L.p. is the 10 percent owner of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .

Flexion Therapeutics Inc (FLXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Flexion Therapeutics Inc Insider Transactions

No Available Data

Versant Venture Capital Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Venture Capital Iii, L.p.. You might contact Versant Venture Capital Iii, L.p. via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.

Discussions on Versant Venture Capital Iii, L.p.

No discussions yet.